The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response againstPseudomonas aeruginosain a Murine Model of Pneumonia
Authors:
Open Access
- 1 May 2004
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (5) , 2899-2906
Abstract
Pseudomonas aeruginosais a leading cause of hospital-acquired pneumonia, and approximately 80% of patients with cystic fibrosis are infected with this bacterium. To investigate the overall role of complement and the complement activation pathways in the host defense againstP. aeruginosapulmonary infection, we challenged C3-, C4-, and factor B-deficient mice withP. aeruginosavia intranasal inoculation. In these studies, C3−/−mice had a higher mortality rate than C3+/+mice. Factor B−/−mice, but not C4−/−mice, infected withP. aeruginosahad a mortality rate similar to that of C3−/−mice, indicating that in this model the alternative pathway of complement activation is required for the host defense againstPseudomonasinfection. C3−/−mice had 6- to 7-fold more bacteria in the lungs and 48-fold more bacteria in the blood than did C3+/+mice at 24 h postinfection. In vitro, phagocytic cells from C3+/+or C3−/−mice exhibited a decreased ability to bind and/or ingestP. aeruginosain the presence of C3-deficient serum compared to phagocytic cells in the presence of serum with sufficient C3. C3−/−mice displayed a significant increase in neutrophils in the lungs and had higher levels of interleukin-1β (IL-1β), IL-6, IL-10, KC, and MIP-2 in the lungs at 24 h postinfection than did C3+/+mice. Collectively, these results indicate that complement activation by the alternative pathway is critical for the survival of mice infected withP. aeruginosaand that the protection provided by complement is at least in part due to C3-mediated opsonization and phagocytosis ofP. aeruginosa.Keywords
This publication has 44 references indexed in Scilit:
- Generation and Characterization of a Protective Monoclonal Antibody toPseudomonas aeruginosaPcrVThe Journal of Infectious Diseases, 2002
- Lung Infections Associated with Cystic FibrosisClinical Microbiology Reviews, 2002
- Human Monoclonal Antibodies againstPseudomonas aeruginosaLipopolysaccharide Derived from Transgenic Mice Containing Megabase Human Immunoglobulin Loci Are Opsonic and Protective against Fatal Pseudomonas SepsisInfection and Immunity, 2001
- Innate Lung Defenses and CompromisedPseudomonas aeruginosaClearance in the Malnourished Mouse Model of Respiratory Infections in Cystic FibrosisInfection and Immunity, 2000
- Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement DepositionInfection and Immunity, 2000
- Macrophage Inflammatory Proteins: Biology and Role in Pulmonary InflammationExperimental Lung Research, 1994
- MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEMAnnual Review of Biochemistry, 1988
- Early bacterial clearance from murine lungs. Species-dependent phagocyte response.Journal of Clinical Investigation, 1980
- The effect of complement depletion on lung clearance of bacteria.Journal of Clinical Investigation, 1978
- Factors in Human Serum Promoting Phagocytosis of Pseudomonas aeruginosa. I. Interaction of Opsonins with the BacteriumThe Journal of Infectious Diseases, 1974